Our findings unravel a novel mechanism by which MIIP suppresses tumorigenesis in triple-negative breast cancer, and MIIP is thus a promising molecular biomarker or therapeutic target for the disease. The gene discussed is MIIP; the disease is triple-negative breast carcinoma.